Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,770 total articles

Results of Annual General Meeting

Results of Annual General Meeting

Diversified Energy Company reported that all resolutions at its Annual General Meeting held on May 6, 2026, were approved by shareholders with overwhelming support. The resolutions included the re-election of board members, ratification of independent auditors, and advisory votes on executive compensation and its frequency. The company emphasizes i…

Amaze Holdings, Inc. Comments on Unusual Market Activity

Amaze Holdings, Inc. Comments on Unusual Market Activity

Amaze Holdings, Inc., a creator-powered commerce platform, has issued a statement regarding unusual market activity in its stock. After reviewing recent unusual trading volume and price movements, the company confirmed that no new material information or developments have occurred beyond previously disclosed facts. Amaze emphasized its commitment t…

ITW Board of Directors Declares Quarterly Dividend

ITW Board of Directors Declares Quarterly Dividend

Illinois Tool Works Inc., a global multi-industrial manufacturing leader, has declared a quarterly dividend of $1.61 per share for the second quarter of 2026, reflecting a full-year dividend of $6.44 per share. The dividend will be paid on July 10, 2026 to shareholders of record as of June 30, 2026.

Brunswick Corporation Collaborates with Textron Systems on TSUNAMI® Uncrewed Surface Vessel Deliveries for DIU, U.S. Navy Fourth Fleet and SOUTHCOM

Brunswick Corporation Collaborates with Textron Systems on TSUNAMI® Uncrewed Surface Vessel Deliveries for DIU, U.S. Navy Fourth Fleet and SOUTHCOM

Brunswick Corporation announced a collaboration with Textron Systems to supply vessels, propulsion, and electronics for the TSUNAMI Uncrewed Surface Vessels, following a Defense Innovation Unit contract. These USVs participated in U.S. Navy Fleet Experimentation exercises and support ongoing joint operations with U.S. Southern Command and the Fourt…

CORRECTING and REPLACING -- AppTech Appoints Albert L. Lord as Executive Chairman and Adds Robert L. Lipstein to Board of Directors

CORRECTING and REPLACING -- AppTech Appoints Albert L. Lord as Executive Chairman and Adds Robert L. Lipstein to Board of Directors

AppTech Payments Corp. announced the appointment of Albert L. Lord as Executive Chairman to support CEO Thomas DeRosa in managing the company's rapid growth and increasing operational complexities. The company also added Robert L. Lipstein, a former KPMG Global SOX Leader, to its Board of Directors to enhance compliance and governance capabilities.…

Navy Pier Names RYTHM as Its Official THC Beverage Partner

Navy Pier Names RYTHM as Its Official THC Beverage Partner

RYTHM, Inc., a Nasdaq-listed company, has been named the official THC beverage partner of Navy Pier, the Midwest's top tourist destination, in a multi-year agreement launching May 22, 2026. The partnership will feature RYTHM’s full lineup of hemp-derived THC beverages, including Sativa, Kush, and Señorita THC Margaritas, served at the Navy Pier Bee…

Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million

Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million

Cytokinetics has successfully closed an underwritten public offering including full exercise of underwriters’ option, raising approximately $805 million in gross proceeds. The company will use the funds to advance its pipeline of cardiovascular therapeutics, including the approved drug MYQORZO® and investigational treatments omecamtiv mecarbil and …

New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market

New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market

PatentVest's latest report analyzes 27 global triple-agonist obesity drug programs, highlighting Eli Lilly's retatrutide as a frontrunner with near bariatric surgery efficacy. The report emphasizes that future market leadership will hinge on intellectual property strategies, receptor engineering, and delivery platforms beyond clinical outcomes. It …

E-Power Granted Landmark Patent for Multi-Element Doped Hard Carbon Composites, Accelerating Sodium-Ion Battery Commercialization

E-Power Granted Landmark Patent for Multi-Element Doped Hard Carbon Composites, Accelerating Sodium-Ion Battery Commercialization

E-Power Inc., a Nasdaq-listed company specializing in AI Data Center microgrid solutions and advanced battery materials, announced the granting of a key patent for its proprietary phosphorus-silver-silicon co-doped hard carbon composite. This innovation enhances sodium-ion battery anode performance, increasing capacity, stability, and operational b…

Lamar Advertising to appear at the J.P. Morgan 2026 Global Technology, Media and Communications Conference

Lamar Advertising to appear at the J.P. Morgan 2026 Global Technology, Media and Communications Conference

Lamar Advertising Company announced that CEO Sean Reilly will participate in a Q&A session at the J.P. Morgan 2026 Global Technology, Media and Communications Conference. The session will be webcast live and archived for 30 days. Lamar Advertising is one of North America's largest outdoor advertising companies, operating over 359,000 displays inclu…

Genie Energy to Report First Quarter 2026 Results

Genie Energy to Report First Quarter 2026 Results

Genie Energy Ltd. (NYSE: GNE) will release its financial and operational results for the first quarter of 2026 on May 14, 2026, followed by a management conference call to discuss the results, business outlook, and strategy. Additionally, the company has rescheduled its annual stockholders meeting to June 10, 2026.

NRSInsights’ April 2026 Retail Same-Store Sales Report

NRSInsights’ April 2026 Retail Same-Store Sales Report

National Retail Solutions (NRS), a subsidiary of IDT Corporation, announced a 3.9% increase in retail same-store sales for April 2026 compared to April 2025. This growth was driven by higher average spend per transaction despite a slight decrease in transaction counts. Key product categories like prepared cocktails, espresso, and smokeless tobacco …

Sono Group N.V. Completes Exit from Legacy Solar Operations

Sono Group N.V. Completes Exit from Legacy Solar Operations

Sono Group N.V. has finalized the transfer of its legacy solar subsidiary Sono Motors GmbH to its management team, marking a complete exit from solar operations. The company is now fully dedicated to a Treasury Strategy focused on acquiring Bitcoin and generating yield through covered-call approaches under an institutional ISDA framework. With no f…

ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology

ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology

ENvue Medical announced that the USPTO has issued a Notice of Allowance for a patent covering its novel drug delivery system that uses proprietary surface acoustic wave (SAW) ultrasound technology to enhance transdermal delivery of cannabinoid-based therapeutics. The patent covers multiple components of the combined SAW ultrasound and cannabinoid t…

Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma

Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma

Alpha Tau Medical announced a conference call scheduled for May 11, 2026, to discuss interim clinical results from the first three patients treated with its alpha-radiation therapy Alpha DaRT in a U.S. trial for recurrent glioblastoma. The trial aims to evaluate the safety and feasibility of the treatment in up to ten patients with inoperable recur…